DiaMedica Therapeutics (DMAC) Notes Payables (2017)
DiaMedica Therapeutics' (DMAC) quarterly Notes Payables came in at $84000.0 in Q4 2017.
DiaMedica Therapeutics (DMAC) Notes Payables (2017) Analysis & Trends
DiaMedica Therapeutics' Notes Payables history runs 1 years deep, the most recent figure standing at $84000.0 for Q4 2017.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $84000.0 in Q4 2017; TTM through Dec 2017 was $84000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $84000.0, changed N/A from the prior year.
- Notes Payables steadied at $84000.0 in Q4 2017 per DMAC's latest filing.
- Across five years, Notes Payables topped out at $84000.0 in Q4 2017 and bottomed at $84000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DiaMedica Therapeutics | 366.87 Mn | 366.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 84,000.00 |